Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Hong Kong · Delayed Price · Currency is HKD 15.60
+0.01 (0.06%)
Oct 21, 2026, 2:42 PM HKT
HKG:6826 Market Cap
HKG:6826 has a market cap or net worth of 7.28 billion as of October 20, 2026. It is the 10,608th most valuable company in the world and the 521st biggest in Hong Kong. Its market cap has decreased by 36.42% in one year.
Market Cap
7.28B
Enterprise Value
5.20B
Revenue
2.68B
Global Rank
Country Rank
#521 Hong Kong
PE Ratio
20.42
ChartMarket Cap Chart
Since April 30, 2015, HKG:6826's market cap has decreased from 9.34B to 7.28B, a decrease of -22.07%. That is a compound annual growth rate of -2.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 7.28B | -28.39% |
| Dec 31, 2025 | 10.17B | -23.81% |
| Dec 31, 2024 | 13.35B | -24.15% |
| Dec 29, 2023 | 17.60B | 7.10% |
| Dec 30, 2022 | 16.43B | -29.33% |
| Dec 31, 2021 | 23.25B | 40.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Suzhou Ribo Life Science | 9.06B |
| HBM Holdings | 8.81B |
| CStone Pharmaceuticals | 8.13B |
| Nanjing Leads Biolabs | 8.10B |
| Lepu Biopharma | 7.24B |
| Alphamab Oncology | 7.03B |
| CARsgen Therapeutics Holdings | 6.69B |
| Ascletis Pharma | 6.34B |